Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclobenzaprine for sleep bruxism
RBR-3dvy84pPhase 2Recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cyclobenzaprine in sleep bruxism (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Rhythmic masticatory muscle activity during sleep. Started Jan 2024; status: recruiting.
02
Drugs
cyclobenzaprine
03
Conditions
sleep bruxism
Beyond the preview
Go deeper on RBR-3dvy84p.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3dvy84p.